Drug delivery and tissue engineering to promote wound healing in the immunocompromised host: Current challenges and future directions.


As regenerative medicine matures as a field, more promising technologies are being translated from the benchtop to the clinic. However, many of these strategies are designed with otherwise healthy hosts in mind and validated in animal models without other co-morbidities. In reality, many of the patient populations benefiting from drug delivery and tissue… (More)
DOI: 10.1016/j.addr.2017.12.001


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics